U.S. Prescription Drug Denials by Private Insurers Increase 25% from 2016 to 2023
Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.